Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
In this issue
CNV and anti-VEGF therapies
Aqueous flare major risk
Doppler imaging repeatable
Emulsion drops effective
 
Survey

Which eye drops do you prefer to use on dry eye patients?

Click here to vote

You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Felicity Thomas, editor.

Click here to contact Neil Hanley, sales manager.

January 11, 2012
CNV patients are responsive when switching anti-VEGF therapies
Choroidial neovascularisation (CNV) patients are responsive when switching to bevacizumab or ranibizumab after they develop tachyphylaxis during anti-vascular endothelial growth factor (VEGF) therapy. More...
Aqueous flare is a major risk factor for PVR redetachment
Preoperative aqueous flare is a significant risk factor for proliferative vitreoretinopathy (PVR) redetachment in patients with rhegmatogenous retinal detachment. More...
Doppler imaging measurements are repeatable in OAG patients
The repeatability of colour Doppler imaging (CDI) measurements in open-angle glaucoma (OAG) patients has been confirmed by a study published in Journal of Glaucoma. More...
Emulsion drops are most effective for improving tear stability
Administering emulsion drops in dry eye patients improves tear stability and decreases osmolarity and corneal staining. More...
 

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other
opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail
at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH. United Kingdom